Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813559) titled 'Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease' on Sept. 4.
Study Type: Observational [Patient Registry]
Primary Sponsor: Tianjin Medical University
Condition:
Thrombi
Thrombus, Brain
Thrombus
Intervention:
Diagnostic Test: 18F/68Ga-GP1
Recruitment Status: Recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 500
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07813559
Published by HT Digital Content Services with permission from Health Daily Digest....